Cellular Health Screening Market Is Anticipated To Reach $3.8 Billion By 2026: Grand View Research, Inc.

 Breaking News
  • No posts were found

Cellular Health Screening Market Is Anticipated To Reach $3.8 Billion By 2026: Grand View Research, Inc.

November 13
08:26 2019
Cellular Health Screening Market Is Anticipated To Reach $3.8 Billion By 2026: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
The global cellular health screening market size was valued at USD 1.9 billion in 2018 and is anticipated to witness a CAGR of 9.3% during the forecast period.

According to report published by Grand View Research, The global cellular health screening market size is expected to reach USD 3.8 billion by 2026, expanding at a CAGR of 9.3%. Key market drivers include rising adoption of telomere performance programs, increasing importance of healthy adjusted life expectancy (HALE), rising government initiatives for preventive healthcare, and growing prevalence of chronic diseases. Additionally, increasing investments aimed at the improvement in the healthcare sector, rise in R&D, and rapidly growing adoption of direct to customer approach are also expected to drive the market.

Increase in importance of healthy adjusted life expectancy (HALE)is anticipated to be one of the major factors boosting market potential for cellular health screening during the forecast period. According to WHO, U.S. is among one of the top five countries that has witnessed decrease in HALE due to rising use of drugs such as opioids, leading to drug overdoses. Similarly, according to the World Economic Forum in 2016, HALE in Japan has slightly decreased from 85.7 to 83.7, due to adoption of unhealthy lifestyles. However, HALE in Spain is 85.8, which has improved due to the consumption of the Mediterranean diet that prevents obesity, high blood pressure, and others.

The length of telomere gets shorter with age, which has a negative effect on health. Telomere shortening can cause various health problems such as heart diseases, cancer, and arthritis. Telomere testing can be used to understand cellular age, facilitating patients to take preventive steps such as regular cellular health screening to prevent telomere shortening. According to UNFPA, in 2017, the ageing population was 11.5 % of the overall 7 billion population, which is expected to rise to 22.0% in 2050. Thus, an increase in geriatric population is also one of the factors expected to fuel the growth of the telomere tests segment, globally.

The Asia Pacific region is anticipated to witness the highest CAGR during the forecast period owing to rise in government initiatives for preventive healthcare. For instance, in 2018, the government of Australia invested USD 10 million in research with an aim to prevent diseases and promote better health choices. This research would be conducted by The Australian Prevention Partnership Center (TAPPC) with a purpose to develop effective guidance tools and promote healthy practices in the country.

Acquisitions done by major market players are anticipated to drive demand for cellular health screening tests. For instance, Quest Diagnostics in 2018 acquired Boyce & Bynum Pathology Laboratories, P.C. to expand its facilities. The aim of this strategic initiative is to bring a broad menu of innovative clinical pathology services and clinical laboratories in Missouri, U.S. Additionally, this relationship will allow patients to access an extended network of service centers across the region in order to provide greater convenience.

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/6765/ibb

Further key findings from the report suggest:

  • Single test panels held the largest share by test type owing to ease of usage, cost effectiveness, and accuracy provided by these tests

  • Telomere tests are expected to witness the highest growth rate during the forecast period due to increasing awareness and rising number of market players offering tests at consumer friendly prices

  • Saliva-based sample testing is anticipated to witness the highest growth rate owing to increasing awareness, coupled with rising number of tests that cater to easy, at-home testing

  • North America held the largest market share due to the presence of a large number of market players and the availability of technologically advanced infrastructure

  • Key players of cellular health screening market included Titanovo; Telomere Diagnostics Inc.; Cell Science Systems; Life Length; Genova Diagnostics; Spectracell Laboratories; Repeat Diagnostics Inc.; Segterra, Inc.; Quest Diagnostics; Labcorp Holdings; Immundiagnostik AG; Bioreference Laboratories; Cleveland Heartlab, Inc.; Zimetry LLC, and DNA Labs India. 

To request a sample copy or view summary of this report, click the link below:

Grand View Research has segmented the global cellular health screening market on the basis of test type, sample, collection site, and region:

Cellular Health Screening Test Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Single Test Panels

    • Telomere

    • Oxidative stress

    • Inflammation

    • Heavy

  • Multi Test Panels

Cellular Health Screening Sample Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Blood

  • Saliva

  • Serum

  • Urine

Cellular Health Screening Collection Site Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Home

  • Offices

  • Hospitals

  • Diagnostic Labs

Cellular Health Screening Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/cellular-health-screening-market

Related Articles